Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adrenal cortex steroidogenic pathway enzymes are a group of enzymes responsible for the biosynthesis of steroid hormones—including glucocorticoids, mineralocorticoids, and some sex steroids—from cholesterol. These enzymes are highly expressed in the adrenal cortex and include members from two main families: cytochrome P450s (such as CYP11A1 [cholesterol side-chain cleavage], CYP21A2 [21-hydroxylase], CYP11B1 [11β-hydroxylase], and CYP11B2 [aldosterone synthase]) and hydroxysteroid dehydrogenases/ketosteroid reductases. Their coordinated activity enables stepwise conversion from cholesterol to active hormones like cortisol and aldosterone. Defects or inhibition in these pathways can lead to endocrine disorders such as congenital adrenal hyperplasia or Cushing’s syndrome. Drugs targeting these enzymes are used therapeutically but may cause significant safety concerns due to disruption of essential hormone synthesis[1][2][3][4].
Inhibition of specific cytochrome P450 or hydroxysteroid dehydrogenase enzymes to reduce synthesis of cortisol, aldosterone, or other steroids
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenal cortex steroidogenic pathway enzyme.